Keeping Track: US FDA Approves Sickle Cell Therapy Endari; Array Submits Binimetinib Again

 
• By Bridget Silverman

The latest drug development news and highlights from our FDA Performance Tracker.

Keeping Track Feature image

More from Product Reviews

More from Pink Sheet